Author

N. Strydom

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Deitchman· 1 shared E. Nuermberger· 1 shared J. J. N. Goh· 1 shared J. P. Ernest· 1 shared N. Zhang· 1 shared Q. Wang· 1 shared R. C. van Wijk· 1 shared R. M. Savic· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Deitchman

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Translational predictions of phase 2a first-in patient efficacy studies for antituberculosis drugs

R. M. Savic, J. J. N. Goh, J. P. Ernest, N. Strydom, Q. Wang, R. C. van Wijk, N. Zhang, A. Deitchman, E. Nuermberger

The paper predicts clinical efficacy of antituberculosis drugs using preclinical PKPD data and translational pharmacology models to reduce phase 2a trial costs and failures.

bioRxiv · Jan 18, 2023Pharmacology & Toxicology